Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase I crossover pharmacokinetic study of TMC114 + TMC41629 controlled-release versus immediate-release coformulations in healthy men
NL-OMON32892Phase 1Active, not recruiting
- Sponsor
- Tibotec
- Start
- Nov 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label trial of darunavir and ritonavir in human immunodeficiency virus infection (HIV) (3 arms), sponsored by Tibotec. Primary endpoint: Relative bioavailability and plasma concentration-time profile comparison. Started Nov 2008; status: active, not recruiting.
02
Drugs
darunavirritonavir
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on NL-OMON32892.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON32892.